Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma

Gastroenterology

Volumn 135, Issue 3, 2008, Pages

  Ma, Cheng Lung ^a   Hsu, Cheng Lung ^a,b   Wu, Ming Heng ^a   Wu, Chun Te ^a,b   Wu, Cheng Chia ^a   Lai, Jiann Jyh ^a   Jou, Yuh Shan ^c   Chen, Chun Wei ^a   Yeh, Shuyuan ^a   Chang, Chawnshang ^a  

^a Cancer Center   (United States)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRESS; DNA DAMAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 51249105211     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.05.046     Document Type: Article

References (29)

1. Tejura S., Rodgers G.R., Dunion M.H., et al. Sex-steroid receptors in the diethylnitrosamine model of hepatocarcinogenesis: modifications by gonadal ablation and steroid replacement therapy. J Mol Endocrinol 3 (1989) 229-237
2. Groupe d'Etude et de Traitement du Carcinome He'patocellulaire. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen. Hepatology 40 (2004) 1361-1369
3. Chang C.S., Kokontis J., and Liao S.T. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240 (1988) 324-326
4. Heinlein C.A., and Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev 23 (2002) 175-200
5. Lin H.-Y.I.-C.Y., Wang R.-S., Chen Y.-T., et al. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 47 (2008) 1924-1935
6. Yeh S., Tsai M.Y., Xu Q., et al. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci U S A 99 (2002) 13498-13503
7. Yeh S., Hu Y.C., Wang P.H., et al. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. J Exp Med 198 (2003) 1899-1908
8. Ostrowski J.L., Ingleton P.M., Underwood J.C., et al. Increased hepatic androgen receptor expression in female rats during diethylnitrosamine liver carcinogenesis. A possible correlation with liver tumor development. Gastroenterology 94 (1988) 1193-1200
9. Pikarsky E., Porat R.M., Stein I., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
10. Maeda S., Kamata H., Luo J.L., et al. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121 (2005) 977-990
11. Lim G.P., Chu T., Yang F., et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21 (2001) 8370-8377
12. Ichinose T., Nobuyuki S., Takano H., et al. Liver carcinogenesis and formation of 8-hydroxy-deoxyguanosine in C3H/HeN mice by oxidized dietary oils containing carcinogenic dicarbonyl compounds. Food Chem Toxicol 42 (2004) 1795-1803
13. Hussain S.P., Schwank J., Staib F., et al. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26 (2007) 2166-2176
14. Gramantieri L., Chieco P., Giovannini C., et al. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation. Hum Pathol 36 (2005) 1154-1162
15. Qiu W., David D., Zhou B., et al. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol 162 (2003) 1961-1974
16. Yang Z., Chang Y.J., Yu I.C., et al. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat Med 13 (2007) 348-353
17. Nagasue N., Ito A., Yukaya H., et al. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma. Gastroenterology 89 (1985) 643-647
18. Eagon P.K., Elm M.S., Epley M.J., et al. Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. Gastroenterology 110 (1996) 1199-1207
19. Yeh S.H., Chiu C.M., Chen C.L., et al. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. Int J Cancer 120 (2007) 1610-1617
20. Yeh S., Lin H.K., Kang H.Y., et al. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci U S A 96 (1999) 5458-5463
21. Miyamoto H., Yang Z., Chen Y.T., et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99 (2007) 558-568
22. Yeh S., Miyamoto H., and Chang C. Hydroxyflutamide may not always be a pure antiandrogen. Lancet 349 (1997) 852-853
23. Miyamoto H., Yeh S., Lardy H., et al. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc Natl Acad Sci U S A 95 (1998) 11083-11088
24. Yuan J.M., Ross R.K., Stanczyk F.Z., et al. A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer 63 (1995) 491-493
25. Yu L., Kubota H., Imai K., et al. Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1). Liver 17 (1997) 35-40
26. Zheng Y., Chen W.L., Ma W.L., et al. Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology 363 (2007) 454-461
27. Lampropoulou-Karatzas C., Goritsas P., and Makri M.G. Low serum testosterone: a special feature of hepatocellular carcinoma. Eur J Med 2 (1993) 23-27
28. Forbes A., Wilkinson M.L., Iqbal M.J., et al. Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone. Eur J Cancer Clin Oncol 23 (1987) 1659-1664
29. Jie X., Lang C., Jian Q., et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 26 (2007) 5741-5751